Brain Development Altered in Attention-Deficit/hyperactivity Disorder
[read article]
FEB 9, 2009
Children with attention-deficit/hyperactivity disorder (ADHD) have alterations in the development of parts of the cortico-striato-thalamo-cortical network, according to a report in the December Archives of General Psychiatry...[read article]
FDA Approves Focalin XR for ADHD
[read article]
FEB 8, 2009
The US Food and Drug Administration has approved dexmethylphenidate HCl extended-release capsules (Focalin XR, Novartis) for the treatment of attention-deficit/hyperactivity disorder (ADHD), according to Novartis news release ...[read article]
ADHD Medications Do Not Cause Chromosomal Damage in Children
[read article]
FEB 04, 2009
Contrary to recent research, new evidence shows that therapeutic doses of stimulant medications, including methylphenidate (MPH)- and amphetamine-based drugs, which are widely used to treat attention-deficit/hyperactivity disorder (ADHD)...[read article]
ADHD Affects Motor Control in Boys More Than Girls
[read article]
FEB 03, 2009
Girls with attention-deficit/hyperactivity disorder (ADHD) are twice as likely to be able to control their movements for their age compared with boys, a new study has found. Reporting in the November 4 issue of Neurology...[read article]
Early Childhood Injury Increases ADHD Risk
[read article]
FEB 01, 2009
Young children with medically attended injury before the age of 2 years are more likely to have a subsequent diagnosis of attention-deficit/hyperactivity disorder (ADHD), a new study suggests ...[read article]
The Gene For ADHD May Have Benefited Our Nomadic Ancestors
[read article]
Janu 26, 2009
An ADHD-associated version of the human gene DRD4 is linked to better health among nomadic tribesmen, but may cause malnourishment in their settled cousins, according to new research by a team directed by an anthropologist at the University of Wisconsi...[read article]
Ritalin-style Drug Set For Wider Role In Adult Mental Illness
[read article]
Janu 24, 2009
A significant number of adults with unresolved depression, anxiety or addiction may actually have Attention Deficit Hyperactivity Disorder (ADHD), a condition that has been widely considered to resolve in late adolescencee...[read article]
Innovative Program Focuses On Improved Care For Children With ADHD
[read article]
Janu 20, 2009
An innovative program is helping busy primary care physicians improve the care they provide for school-aged children with Attention-Deficit/Hyperactivity Disorder (ADHD), according to a study led by researchers at Cincinnati Children's Hospital Medical Center and published in the July edition of Pediatrics....[read article]
US Pharmacies Now Supply ADHD Medication VYVANSE In 6 Dosage Strengths
[read article]
JANU 18, 2009
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that is now available in U.S. pharmacies nationwide in three additional dosage strengths, bringing the total number to six: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. The expanded VYVANSE dosing options will allow physicians to individualize treatment for each patient...[read article]
